Rhabdomyolysis after taking Atorvastatin with Gemfibrozil

Paul Duell, William E. Connor, D. Roger Illingworth

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

Original languageEnglish (US)
Pages (from-to)368-369
Number of pages2
JournalAmerican Journal of Cardiology
Volume81
Issue number3
DOIs
StatePublished - Feb 1 1998

Fingerprint

Gemfibrozil
Rhabdomyolysis
Myositis
Oxidoreductases
Atorvastatin Calcium
3-hydroxy-3-methylglutaryl-coenzyme A

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Rhabdomyolysis after taking Atorvastatin with Gemfibrozil. / Duell, Paul; Connor, William E.; Illingworth, D. Roger.

In: American Journal of Cardiology, Vol. 81, No. 3, 01.02.1998, p. 368-369.

Research output: Contribution to journalArticle

Duell, Paul ; Connor, William E. ; Illingworth, D. Roger. / Rhabdomyolysis after taking Atorvastatin with Gemfibrozil. In: American Journal of Cardiology. 1998 ; Vol. 81, No. 3. pp. 368-369.
@article{d3103f7b085b4ce8a6fba182015dcb61,
title = "Rhabdomyolysis after taking Atorvastatin with Gemfibrozil",
abstract = "The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.",
author = "Paul Duell and Connor, {William E.} and Illingworth, {D. Roger}",
year = "1998",
month = "2",
day = "1",
doi = "10.1016/S0002-9149(97)00907-7",
language = "English (US)",
volume = "81",
pages = "368--369",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Rhabdomyolysis after taking Atorvastatin with Gemfibrozil

AU - Duell, Paul

AU - Connor, William E.

AU - Illingworth, D. Roger

PY - 1998/2/1

Y1 - 1998/2/1

N2 - The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

AB - The findings in this case indicate that atorvastatin, like other DL-3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase the risk of myositis and rhabdomyolysis when used in combination with gemfibrozil.

UR - http://www.scopus.com/inward/record.url?scp=0032005257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032005257&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(97)00907-7

DO - 10.1016/S0002-9149(97)00907-7

M3 - Article

C2 - 9468088

AN - SCOPUS:0032005257

VL - 81

SP - 368

EP - 369

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 3

ER -